Reports global Q1 Orencia sales $770M, down 2% y/y; Q1 Yervoy sales $624M, up 9% y/y.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMY:
- Bristol Myers reports Q1 EPS $1.80, consensus $1.50
- Bristol Myers raises FY25 EPS view to $6.70-$7.00 from $6.55-$6.85
- Options Volatility and Implied Earnings Moves Today, April 24, 2025
- Optimistic Buy Rating for Bristol-Myers Squibb Amid Low Valuation and Promising Pipeline
- Notable companies reporting before tomorrow’s open